| 2022 | | S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus | 김지원, 김현아, 서창희, 정주양 |
| 2021 | | Salivary immunoglobulin gamma-3 chain c is a promising noninvasive biomarker for systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2024 | | Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus | 김지원, 김현아, 백욱영, 서창희, 정주양 |
| 2013 | | Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus. | 김현아, 서창희, 전자영, 정주양 |
| 2022 | | Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus: Case report | 김지원, 김현아, 서창희, 정주양 |
| 2012 | | Systemic lupus erythematosus and hypercalcaemia: comment on the article by TP Karageorgas et al | 박세진, 박준은 |
| 2003 | | T cell reactivity to MHC class II-bound self peptides in systemic lupus erythematosus-prone MRL/lpr mice. | 서창희 |
| 2010 | | TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. | 서창희 |
| 2003 | | The effects of anti-idiotypic antibody on antibody production and apoptosis of anti-dsDNA antibody producing cells. | 서창희 |
| 2013 | | The interleukin 6 receptor alpha gene polymorphisms are associated with clinical manifestations of systemic lupus erythematosus in Koreans. | 김현아, 서창희, 전자영 |
| 2011 | | The link of HLA-B27 with interleukin-23/interleukin-17 axis in coexisting systemic lupus erythematosus and ankylosing spondylitis. | 박세진, 배기수 |
| 2017 | | The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis | 김현아, 서창희, 정주양 |
| 2014 | | The role of interleukin-17 in the associations between systemic lupus erythematosus and ANCA-associated vasculitis Comment on: systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome? (Rheumatol Int. 2012 Oct; 32(10):3285–3290) | 박세진 |
| 2013 | | The role of interleukin-23/interleukin-17 axis in the development of systemic lupus erythematosus among patients with tuberculosis: comment on: Lin YC, Liang SJ, Liu YH et al.: tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. (Rheumatol Int. 2011 Mar 18. [Epub ahead of print]). | 박세진 |
| 2011 | | The significance of T helper 1 cell-derived cytokines in patients with systemic lupus erythematosus with acquired thrombotic thrombocytopenic purpura. | 박세진 |
| 2018 | | The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus | 서창희, 정주양 |
| 2016 | | Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients | 김현아, 서창희, 정주양 |
| 2021 | | Toll‐like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus | 서창희 |
| 2017 | | Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
| 2005 | | Variable region genes of human monoclonal autoantibodies to histones H2A and H2B from a systemic lupus erythematosus patient. | 신규태, 이수영, 장영주 |
| 2012 | | Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries | 서창희 |
| 2011 | | Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. | 김현아, 서창희 |
